Return
Company Page
Novoic
Founders
Novoic is a clinical-stage digital biotechnology company developing AI-powered speech analysis algorithms to detect neurological diseases like Alzheimer's and Parkinson's in their preclinical stages, decades before traditional diagnosis. The company's 10-minute speech-based test analyzes audio-linguistic patterns to identify subtle cognitive impairment and is used in late-stage clinical trials. Founded by researchers from Oxford and Cambridge University, Novoic is working to make early detection accessible globally through its software-as-medical-device platform.
Company Founded in 2019
Healthtech & Biotech